China Health Report: NHC Data Shows Life Expectancy at 79.25 Years as Health Spending Reaches 6.7% of GDP
The National Health Commission of China (NHC) released the Statistical Bulletin on Health Development in...
NHC (NHFPC)
China’s NHC Issues Notice Deepening “Six Expansions” to Strengthen Family Doctor Contracted Services With AI Integration
China’s National Health Commission (NHC), together with the National Administration of Traditional Chinese Medicine and...
China NHC Mandates Priority Use of Essential Medicines as 2026 National List Takes Effect
China’s National Health Commission (NHC), together with the National Administration of Traditional Chinese Medicine and...
China’s Health Authorities Issue Comprehensive Medical Equipment Centralized Procurement Framework with Tiered Implementation and High-Value Equipment Database
The National Health Commission (NHC), National Administration of Traditional Chinese Medicine (NATCM), and National Disease...
China’s National Health Commission Launches Comprehensive Continuous Medication Management Framework to Enhance Patient Safety and Healthcare Quality
The National Health Commission (NHC) of the People’s Republic of China issued the Notice on...
China’s National Health Commission Unveils 2026 Essential Medicines List, Adding 116 New Drugs with Full Insurance Coverage
China’s National Health Commission (NHC) has released the National Essential Medicines List (NEML) 2026 Edition,...
China Adds Methoxyethyl Etomidate, Loretomidate and Solriamfetol to Controlled Psychotropic Substances List
China’s National Medical Products Administration (NMPA), in coordination with the Ministry of Public Security and...
China’s National Health Commission Revises Physician Practice Regulations to Align with Physicians Law and Enhance Multi-Site Practice Framework
The National Health Commission (NHC) announced comprehensive revisions to five key regulatory frameworks governing physician...
China’s Four Health Regulators Issue Revised Good Clinical Practice Guidelines Effective September 2026, Strengthening Trial Oversight and Ethical Standards
China’s National Medical Products Administration (NMPA), National Health Commission (NHC), National Administration of Traditional Chinese...
China’s National Health Commission Launches Anti-Corruption Campaign Targeting Pharmaceutical Sales and Healthcare Services Misconduct
China’s National Health Commission (NHC) released the “Notice on Key Points for Rectifying Misconduct in...
China’s NHC Releases Sixth Pediatric Drug Priority List – 27 Varieties Including Emicizumab, Pembrolizumab, and Omalizumab Targeted for Development
China’s National Healthcare Commission (NHC) announced the release of its sixth batch of pediatric drugs...
China Issues National Guidelines for Home Hospital Bed Services to Address Healthcare Access for Vulnerable Populations
China’s National Health Commission (NHC) and the National Administration of Traditional Chinese Medicine (NATCM) issued...
China’s Seven Ministries Issue Revised Pharmaceutical Representative Management Measures to Combat Commercial Bribery and Strengthen Industry Oversight
China’s National Medical Products Administration (NMPA), in coordination with six other regulatory bodies, has jointly...
China’s NHC Unveils 16-Point Pediatric Medicines Reform to Strengthen Supply Security and Clinical Access
China’s National Health Commission (NHC) released comprehensive “Implementation Opinions on Reforming and Improving the Supply...
China Elevates Pediatric Healthcare Infrastructure – NHC Expands National Children’s Medical Center Network to 14 Facilities
China’s National Health Commission (NHC) announced a significant expansion of the country’s pediatric healthcare infrastructure,...
China’s NHC Establishes Regulatory Framework for Biomedical New Technologies with Interim Guiding Principles Effective May 1, 2026
The National Health Commission (NHC) of China has implemented the Guiding Principles for Defining Biomedical...
China NHC Elevates Chikungunya and SFTS to Category B Status – Enhanced Surveillance and Control Measures Effective April 2026
China’s National Health Commission (NHC) announced that chikungunya fever and severe fever with thrombocytopenia syndrome...
China NHC Issues Medical Technology Evaluation Procedures – New Framework Triggers Restrictions or Bans on Controversial Clinical Practices
China’s National Health Commission (NHC) issued the “Work Procedures for Evaluating the Clinical Application of...
China Unveils NHSA Grassroots Healthcare Reform – 14‑Point Guidance Targets RMB Fund Flow Shift to Primary Care Institutions
China’s National Healthcare Security Administration (NHSA), jointly with the National Development and Reform Commission and...
Beijing Online Consultation Pilot Gets NHC Approval for Children’s Care
China’s National Health Commission (NHC) has approved the “Standardized Pilot Program for Online Initial Consultations...